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sion became uniformly increased in hypertrophic chondrocytes,
whereas CD36 expression developed most robustly at sites of
the most intense injury. We demonstrated that forced expres-
sion of CD36 blocked the capacity of S100A11, TNFalpha and
CXCL8 to induced chondrocyte hypertrophy. CD36 also blocked
the capacity of S100A11 to inhibit proteoglycans synthesis. Last,
the PPARgamma agonist N-(2-Benzoylphenyl)-O-[2-(methyl-2-
pyridinylamino)ethyl]-L-tyrosine hydrate induced CD36 expres-
sion without affecting RAGE expression in chondrocytes.
Conclusions: Early induction of CD36 expression by chon-
drocytes occurs at sites of cartilage injury as OA develops
experimentally. PPARgamma ligation, which is chondroprotec-
tive, induces chondrocyte CD36 expression in vitro. Chondrocyte
CD36 expression suppresses the capacity of not only its ligand
S100A11, but also of TNFalpha and CXCL8 to induce chon-
drocyte hypertrophy, and CD36 expression promotes preserva-
tion of proteoglycans synthesis. We conclude that chondrocyte
expression of CD36 is chondroprotective by disengaging re-
sponsiveness to inﬂammation from dysregulated chondrocyte
differentiation and function.
40
THE “ALARMIN” S100 A8: AN ACTIVATOR OF
CHONDROCYTE MEDIATED CARTILAGE DAMAGE?
P. van Lent1, L. Grevers1, A. Blom1, A. Sloetjes1, T. Vogl2,
W. Nacken2, J. Roth2, W. van den Berg1
1Radboud University Medical Centre, Nijmegen, The
Netherlands; 2Inst of Experimental Dermatology, Muenster,
Germany
Purpose: In a previous study we have shown that “alarmins”
S100A8 and S100A9 which can form dimers and are predomi-
nantly produced by myeloid cells in the synovial ﬂuid and synovial
membrane are involved in MMP-mediated cartilage destruction
during experimental arthritis. S100A8 forms the active part which
is stabilized by S100A9 and protects S100A8 from degradation.
As MMP mediated cartilage destruction is particularly found
around the chondrocyte this prompted us to investigate whether
S100A8 and A9 are produced by chondrocytes and whether
these “alarmins” are actively involved in MMP-mediated chon-
drocyte activation.
Methods: S100A8 and A9 proteins were detected in knee
joints of murine arthritis and osteoarthritis using immunolocal-
isation. Murine chondrocyte cell line H4 was stimulated with
pro-inﬂammatory cytokines (100 ng/ml) to investigate rS100A8
and A9 production or by recombinant S100A8 (0.2, 1 and 5
µg/ml) to investigate MMP and cytokine production.mRNA and
protein levels were measured using RT-PCR and blotanalysis.
S100A8/A9 dimers and cytokines were measured in culture su-
pernatant using ELISA and Luminex. Breakdown of aggrecan on
the pericellular surface of the chondrocyte was measured us-
ing VDIPEN and NITEGE (MMP and aggrecanase neoepitopes)
antibodies and FACS analysis.
Results: Immunolocalisation of inﬂamed knee joints depicted
that S100A8 and S100A9 proteins were abundantly expressed in
chondrocytes. Expression was particularly found in the superﬁcial
layers of the cartilage surfaces at the margins of the joint. Stim-
ulation of murine chondrocytes by pro-inﬂammatory cytokines
IL-17, IL-18 and IFNγ caused strong upregulation of particularly
S100A8 and in lesser extent S100A9 mRNA (S100A8: 24, 48
and 4 fold and S100A9: 4, 4 and 0 fold respectively). Stimulation
of chondrocytes by rS100A8 caused a signiﬁcant autoinduction
of S100A8 and in lesser extend upregulation of S100A9 mRNA
and protein levels. High concentrations of cytokines IL-6, KC and
RANTES were measured in the culture supernatant whereas
TNFα, IL-1α and β were below detection level. S100A8/A9 dimers
could not be detected by ELISA conﬁrming that S100A8 is the
active component and can directly activate chondrocytes. More-
over MMPs (-2,-3,-9,-13) and ADAMTS(-4,-5) mRNA levels in
the chondrocyte were strongly upregulated (maximal at 1 µg/ml
(4, 4, 3, 16, 8 and 4 times respectively). VDIPEN and NITEGE
neoepitopes on the pericellular membrane of chondrocytes were
signiﬁcantly elevated after stimulation with rS100A8 for 24 hours
in a concentration (0,2, 1 and 5 µg/ml) dependent manner.
(VDIPEN 17,67,108% and NITEGE 8, 33 and 67% respectively).
Conclusions: The alarmin S100A8 is produced by chondro-
cytes and directly activates MMP and aggrecanase mediated
peri-cellular matrix degradation. S100A8 may be an important
mediator of severe cartilage destruction.
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Purpose: S100A4, a member of the S100 family of calcium bind-
ing proteins, has been shown to be increased in OA cartilage and
to stimulate chondrocyte RAGE signaling resulting in increased
expression of MMP-13. Members of S100 family are known to be
secreted into the extra-cellular environment, however the mech-
anism(s) of secretion is not completely understood. The aim of
this study was to determine the pathway involved in secretion of
S100A4 in response to cytokines in chondrocytes.
Methods: Human articular chondrocytes isolated from normal
ankle cartilage obtained from tissue donors were cultured in
high density monolayers in media with 10% serum for 5-7 days.
Conﬂuent monolayers were then changed to serum free media
16-18hr prior to treatment with 10ng/ml of IL-7, IL-1β and TNF
α. In some experiments, cells were pre-treated with a JAK-3
inhibitor or Brefeldin-A (BFA), a chemical inhibitor that blocks
classical protein translocation. Immuno-blotting with phospho-
speciﬁc antibodies was used to determine the activation of
signaling proteins. Secretion of S100A4 was measured in the
conditioned media by immuno-blotting with polyclonal antibodies
to S100A4.
Results: Chondrocyte secretion of S100A4 was observed af-
ter treatment with IL-7 and TNFα but not with IL-1β. Treatment
with IL-7 resulted in activation of the JAK/STAT pathway with
increased phosphorylation of JAK-3 and STAT-3. IL-7 stimulation
of S100A4 secretion was inhibited by pretreatment with a JAK-3
inhibitor. In addition, pretreatment with Brefeldin-A (BFA) didn’t
effect the secretion of S100A4 suggesting a pathway indepen-
dent of Golgi-endoplasmic reticulum (classical pathway).
Conclusions: Our study demonstrates for the ﬁrst time that IL-7
or TNFα but not IL-1β can stimulate chondrocyte secretion of
S100A4 via activation of JAK/STAT signaling. We have recently
found that OA chondrocytes produce IL-7 and others have shown
TNFα. These cytokines may contribute to cartilage destruction
through secretion of S100A4 which can function as an autocrine
factor to stimulate MMP-13 production via RAGE.
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Purpose: Synovial inﬂammation in osteoarthritis (OA) patients
has been associated with increased pain, disability, and more
